|
Daily Medical Update
Hemoptysis
Tuesday, April 28, 2026
|
🔬 Practice-Changing Findings
Evidence from recent hemoptysis-specific clinical studies published in the
last 12 months.
|
Indian journal of pharmacology (2025) - Randomized Controlled Trial
Key Findings
- In 56 participants with hemoptysis, nebulized tranexamic acid 500 mg every 8 hours produced greater day-1 reductions in bleeding frequency (63.9% vs. 39.8%; P = 0.012) and quantity (73.4% vs. 51.7%; P = 0.024) than normal saline.
- Complete resolution occurred more often with tranexamic acid than control (63.0% vs. 24.1%; P = 0.003), with no serious adverse drug reactions reported over 8 weeks.
📋 Practice Implication: Nebulized tranexamic acid is not an outpatient substitute for evaluating hemoptysis, but PCPs should know it may be used in ED or inpatient settings as a bridge while definitive imaging, bronchoscopy, or embolization is arranged.
|
American journal of emergency medicine (2025) - Retrospective Cohort Study
Key Findings
- Among 391 adult ED hemoptysis encounters, in-hospital mortality was 4.1%, with ICU admission in 27.4% and bronchial artery embolization planned or performed within 24 hours in 19.2%.
- Mortality was independently associated with active malignancy (adjusted OR 4.07; 95% CI 1.20-13.74) and lower hemoglobin (adjusted OR 0.76 per 1 g/dL; 95% CI 0.62-0.94), with strong model discrimination (AUC 0.884).
📋 Practice Implication: For same-day triage, visible hemoptysis plus known active cancer, falling hemoglobin, recurrent bleeding, hypoxemia, or more than scant volume should push toward ED evaluation rather than outpatient imaging alone.
|
Annals of intensive care (2025) - Retrospective Observational Study
Key Findings
- In 945 ICU patients with severe hemoptysis, 13% required invasive mechanical ventilation within 24 hours, and in-hospital mortality was 8.7%.
- Lung cancer was the leading cause, followed by bronchiectasis, tuberculosis, pneumonia, and aspergillosis; vascular interventional radiology was first attempted in 81% of cases and achieved bleeding control in more than 90%, with major adverse events in 4.4%.
📋 Practice Implication: Severe hemoptysis is an airway and vascular emergency; outpatient management should focus on stabilization, medication review, and rapid transfer to a center with CTA, bronchoscopy, and interventional radiology capability.
|
BMC pulmonary medicine (2025) - Systematic Review
Key Findings
- Across 32 studies of BAE for hemoptysis, leading causes were bronchiectasis (27%), post-tubercular sequelae (17.7%), tuberculosis (15.6%), and lung malignancy (15%).
- Median technical success was 98.1% and median immediate clinical success was 94.0%; recurrence increased over time from 10.6% at 6 months to 23.0% at 1 year, while major complications ranged from 0% to 4.8%.
📋 Practice Implication: Patients with recurrent or clinically significant hemoptysis need follow-up even after successful embolization, because recurrence is common and often reflects persistent disease, recanalization, or new collateral vessels.
|
BMC geriatrics (2026) - Retrospective Observational Study
Key Findings
- Among 1,383 patients age 65 years and older presenting with hemoptysis, minimal bleeding was most common (49.5%) and lung cancer was the leading identified etiology.
- Age, bleeding volume, and biochemical parameters did not significantly predict mortality, and bronchoscopic or embolization procedures had success and safety comparable to reports in younger populations.
📋 Practice Implication: In older adults, do not dismiss small-volume hemoptysis as benign solely because it is minimal; evaluation should be individualized around cancer risk, recurrence, anticoagulants, infection, and physiologic reserve rather than age alone.
|
|
💡
Summary
Recent hemoptysis evidence highlights practical triage and management themes for primary care: identify patients who need urgent ED evaluation, recognize active malignancy and low hemoglobin as higher-risk features, and treat recurrent or more-than-scant bleeding as potentially serious even when the patient appears stable. Acute-care options such as nebulized tranexamic acid and bronchial artery embolization may help control bleeding, but the outpatient role remains rapid risk assessment, medication review, and timely referral for imaging, bronchoscopy, or interventional radiology when indicated.
|
|